In accordance with the prevalence of 40% of PIK3CA variants in the cfDNA of locally advanced BC patients [34], we also detected PIK3CA variants in 22%/11% of all patients in the cfDNA and CTC gDNA fraction. Here, PIK3CA is linked to breast cancer.